Carregant...

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis

Monoclonal antibodies (mAbs) to ErbB-2/HER2 or to its sibling, the epidermal growth factor receptor (EGFR), prolong survival of cancer patients, especially when combined with cytotoxic therapies. However, low effectiveness of therapeutic mAbs and the evolution of patient resistance call for improvem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ben-Kasus, Tsipi, Schechter, Bilha, Lavi, Sara, Yarden, Yosef, Sela, Michael
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651295/
https://ncbi.nlm.nih.gov/pubmed/19218427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0812059106
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!